Electrocore Inc (ECOR) Stock Price, Quote & News

Company Profile

electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also deve...

Industry: Medical Devices

Sector: Healthcare

Phone: 973 290 0097

Fax: 973 290 9171

Website: www.electrocore.com

Address:

200 Forge Way, Suite 205, Rockaway, United States

juice_rock Oct. 24 at 3:39 PM

$ECOR classic pump n' dump

0 · Reply

taxplanr Oct. 24 at 2:31 PM

Using the bodies own mitochondria to combat cancers chronic illnesses and autoimmune diseases is what emf device companies like $ECOR can do Not failed malignantRNA platforms with toxic chemo does $BNTX $MRNA $BMY

0 · Reply

taxplanr Oct. 24 at 2:27 PM

$ECOR

0 · Reply

taxplanr Oct. 23 at 10:48 AM

EMF and red light therapy being used for treating cancers chronic pain and autoimmune diseases $ECOR https://rumble.com/v70nlls-jonathan-otto-joins-silk-to-discuss-red-light-and-pemf-therapy.html?mref=1v6ax&amp;mc=85ofo

0 · Reply

taxplanr Oct. 17 at 11:33 AM

$ECOR emf can be used in combination with diet and other therapies to cure cancer Wait for it

0 · Reply

Moneymastermind99 Oct. 16 at 2:36 PM

🚀 $TGL — Quiet Before the Next Wave? TGL just dropped its 10-K, showing solid progress: revenue up YoY, net losses narrowing, and platform expansion underway. The clean filing clears the path for new catalysts — especially that rumored $100M crypto treasury update and possible F&B flagship expansion tied to its ZCITY platform. Market cap nearly doubled this week despite a price dip — a sign smart money may be positioning early. Eyes on the next 8-K or treasury news drop 👀 Low float + real platform growth + fresh capital strategy = setup for a major squeeze. Similar low-float runners catching volume today: $ECOR , $GWAV , $ITP . 🎯 Short-term PT: $1.20-$1.60 ⚡ Speculative breakout range: $2+ if crypto treasury confirmed. #TGL #Crypto #Fintech #SmallCaps #Momentum

0 · Reply

EvilUrges Oct. 16 at 8:37 AM

$ECOR getting Facebook ads for Truvaga. What I found interesting is a guy named Ben Greenfield was promoting it. I used to follow Ben a long time ago back in his Ironman training days when I was running marathons. Learned a lot from him. About Ben: Ben Greenfield is a biohacker, nutritionist, physiologist, fitness coach, competitive athlete and New York Times bestselling author of 13 books, including the wildly popular titles Beyond Training and Boundless. In the Boundless Cookbook he takes over 20 years of experience in the health industry - along with family recipes inspired by his wife and kids - to produce a creative, unique and mouth-watering collection of never-before-seen recipes.

0 · Reply

cgcapitalresearch Oct. 9 at 6:29 PM

$ECOR Earnings Preview - Scaling Bioelectronic Medicine and Wellness Platforms - We forecast FY26 revenue of $40.5M (+35% YoY), narrowing the GAAP net loss to $(4.1M) and achieving positive EBITDA in 4Q26. At a current EV of just $29M, ECOR trades at ~1× EV/2025E revenue, well below peer averages of 3.5–4.0× for high-growth neuro-device companies. We reiterate our Buy rating and $25 base-case price target, with a $35 bull-case scenario reflecting 5× FY26E revenue.[Read More: https://hubs.ly/Q03M-kPx0]

0 · Reply

taxplanr Oct. 6 at 3:05 PM

$ECOR lender converted $2.5 million of debt into equity at a price of $8.62

1 · Reply

TraderJay85 Oct. 5 at 10:13 PM

This week watch list with support/stop. $EEIQ .4577 stop $NYC 9.40 stop $NIVF 1.76 stop $ECOR 4.90 stop $LVLU 4.90 stop Never hold under support. if it goes below then sell. Jump back in if it comes back to last support. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER ❤️

0 · Reply

electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025

Oct 3, 2025, 4:05 PM EDT - 22 days ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Sep 30, 2025, 8:00 AM EDT - 25 days ago

gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms

Sep 29, 2025, 8:00 AM EDT - 26 days ago

electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium

Sep 22, 2025, 8:00 AM EDT - 4 weeks ago

electroCore's Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire's 2025 Sleep Awards

Sep 9, 2025, 2:21 PM EDT - 6 weeks ago

Ecora Resources PLC (ECOR:CA) Q2 2025 Earnings Call Transcript

Sep 5, 2025, 8:00 AM EDT - 7 weeks ago

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

Sep 4, 2025, 8:00 AM EDT - 7 weeks ago

electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief

Sep 3, 2025, 8:00 AM EDT - 7 weeks ago

electroCore Appoints Elena Bonfiglioli to Board of Directors

Sep 2, 2025, 8:00 AM EDT - 7 weeks ago

electroCore to Participate at H.C. Wainwright Global Investment Conference

Aug 12, 2025, 8:00 AM EDT - 2 months ago

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga

Aug 6, 2025, 11:18 PM EDT - 2 months ago

electroCore, Inc. (ECOR) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 2 months ago

electroCore Announces Second Quarter 2025 Financial Results

Aug 5, 2025, 8:00 AM EDT - 2 months ago

electroCore Appoints James C. Theofilos to the Board of Directors

Jul 23, 2025, 8:00 AM EDT - 3 months ago

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

Jul 22, 2025, 4:05 PM EDT - 3 months ago

electroCore to Participate in Upcoming Investor Conferences

May 7, 2025, 11:16 PM EDT - 6 months ago

electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 6 months ago

electroCore Announces First Quarter 2025 Financial Results

May 2, 2025, 8:00 AM EDT - 6 months ago

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

May 1, 2025, 8:00 AM EDT - 6 months ago

electroCore's Truvaga™ Now Works with the Apple Health app

Apr 30, 2025, 8:00 AM EDT - 6 months ago

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

Apr 17, 2025, 8:00 AM EDT - 6 months ago

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

Apr 16, 2025, 8:00 AM EDT - 6 months ago

electroCore to Participate at the Planet MicroCap Showcase

Apr 3, 2025, 8:00 AM EDT - 7 months ago

electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times

Apr 1, 2025, 8:00 AM EDT - 7 months ago

electroCore to Participate at the Needham Virtual Healthcare Conference

Mar 31, 2025, 8:00 AM EDT - 7 months ago

electroCore Extends VA Contract for Five Years

Mar 12, 2025, 9:36 PM EDT - 8 months ago

electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 8 months ago

electroCore Announces Full Year 2024 Financial Results

Mar 6, 2025, 8:00 AM EST - 8 months ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

Mar 5, 2025, 8:00 AM EST - 8 months ago

electroCore to Participate at Upcoming Investor Conferences

Feb 27, 2025, 8:00 AM EST - 8 months ago

electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

Feb 4, 2025, 8:00 AM EST - 9 months ago

electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 14, 2025, 10:17 AM EST - 10 months ago

electroCore: An Opportunity In Medical And Wellness Device Innovation

Dec 30, 2024, 1:59 PM EST - 10 months ago

electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM

Dec 17, 2024, 4:05 PM EST - 11 months ago

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

Nov 14, 2024, 8:00 AM EST - 1 year ago

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

Nov 13, 2024, 9:18 PM EST - 1 year ago

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 1 year ago

electroCore Announces Third Quarter 2024 Financial Results

Nov 12, 2024, 4:01 PM EST - 1 year ago

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

Oct 14, 2024, 8:00 AM EDT - 1 year ago

electroCore to Participate at LD Micro Main Event VXII

Sep 10, 2024, 8:00 AM EDT - 1 year ago

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

Sep 4, 2024, 8:00 AM EDT - 1 year ago

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 10, 2024, 4:27 AM EDT - 1 year ago

electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 1 year ago

electroCore Announces Second Quarter 2024 Financial Results

Jun 25, 2024, 8:00 AM EDT - 1 year ago

electroCore Announces the Commercial Launch of TAC-STIM™

Jun 3, 2024, 8:30 AM EDT - 1 year ago

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

May 8, 2024, 10:19 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:05 PM EDT - 1 year ago

electroCore Announces First Quarter 2024 Financial Results

May 1, 2024, 8:04 AM EDT - 1 year ago

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

juice_rock Oct. 24 at 3:39 PM

$ECOR classic pump n' dump

0 · Reply

taxplanr Oct. 24 at 2:31 PM

0 · Reply

taxplanr Oct. 24 at 2:27 PM

$ECOR

0 · Reply

taxplanr Oct. 23 at 10:48 AM

0 · Reply

taxplanr Oct. 17 at 11:33 AM

$ECOR emf can be used in combination with diet and other therapies to cure cancer Wait for it

0 · Reply

Moneymastermind99 Oct. 16 at 2:36 PM

0 · Reply

EvilUrges Oct. 16 at 8:37 AM

0 · Reply

cgcapitalresearch Oct. 9 at 6:29 PM

0 · Reply

taxplanr Oct. 6 at 3:05 PM

$ECOR lender converted $2.5 million of debt into equity at a price of $8.62

1 · Reply

TraderJay85 Oct. 5 at 10:13 PM

0 · Reply

AStrokeOfLuck Oct. 3 at 10:26 PM

$ECOR

0 · Reply

TraderJay85 Oct. 1 at 10:04 PM

Watch list with support/stop. i have 38 of these but narrowed them down to 20. Ill attach pic of the whole list though. $AEHL 3.40 stop. $ECOR 4.70 stop $IPDN 3.75 stop. $LVLU 4.65 stop $NYC 9.40 stop. Do not hold under support. You can jump back in if it goes back over support. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER.

0 · Reply

Trekingirl Oct. 1 at 12:26 PM

$ECOR

0 · Reply

taxplanr Sep. 29 at 2:38 PM

$ECOR https://investor.electrocore.com/news-releases/news-release-details/electrocore-announces-reimbursement-approval-gammacoretm

1 · Reply

Thestocktraderhubzee Sep. 29 at 12:14 PM

$ECOR electroCore Announces Its GammaCore Sapphire Non-Invasive Vagus Nerve Stimulation Device Has Been Included In Long-Term Reimbursement Policy By Belgium's National Institute For Health And Disability Insurance

0 · Reply

taxplanr Sep. 26 at 2:02 PM

$ABBV these parkinsons drugs are always nightmares Just about every auto-immune disease can be much better treated with a Truvaga Plus from $ECOR which can relax the whole nervous system without any side effects

0 · Reply

taxplanr Sep. 22 at 1:48 PM

$ECOR Truvaga Plus named Best Relaxation Device 2025 https://investor.electrocore.com/news-releases/news-release-details/electrocores-truvagatm-plus-named-best-relaxation-gadget

0 · Reply

RickAllen817 Sep. 21 at 10:19 AM

$ECOR Medical device innovation. Pre-revenue speculation. High risk/reward setup. No pattern.

0 · Reply

Trekingirl Sep. 19 at 8:42 PM

$ECOR Insiders have been buying over the last year but..... "WHO THE FUCK IS HOLDING THE PRICE BACK ON THIS LOW FLOAT, LOW VOLUME STOCK?" Doesn't see much action now, but when it rips, it'll most likely be HUGE.

0 · Reply

DisMania Sep. 15 at 11:53 AM

$ECOR Yikes, this was nearly $20 earlier this year and it's been a falling knife since. 25 cent stock in the making

0 · Reply

NVDAMillionaire Sep. 11 at 8:52 AM

$ECOR Outstanding article that hits the mark on ECOR's current state. So if you want to refresh your ECOR insights or learn about ECOR from scratch, this is a must read. https://beyondspx.com/quote/ECOR/analysis/electrocore-s-bioelectronic-power-play-diversification-and-growth-in-chronic-pain-and-wellness-nasdaq-ecor

0 · Reply

taxplanr Sep. 10 at 9:59 PM

$ECOR new controller https://investor.electrocore.com/news-releases/news-release-details/electrocore-announces-inducement-grant-under-nasdaq-listing-2

0 · Reply

Market Cap	39.18M
Revenue (ttm)	25.18M
Net Income (ttm)	-11.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47.22%
Debt to Equity Ratio	0.00

Volume	48,600
Avg Vol	52,588
Day's Range	N/A - N/A
Shares Out	8.00M
Stochastic %K	49%
Beta	0.34
Analysts	Strong Sell
Price Target	$21.35